Search results for “Mesothelin Antibody” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 124 patents, we discovered top 26 key players by total patent application. Mogam Institute For Biomedical Research, Green Cross Corp., Silverback Therapeutics, Inc. are dominant in this area. They take 47.58% of the total patent filing.
Mogam Institute For Biomedical Research
Chungcheongnam-do, South Korea
Patent: 25
Green Cross Corp.
South Korea
Patent: 22
Silverback Therapeutics, Inc.
Washington, United States
Patent: 12
Bristol Myers Squibb Co.
New York, United States
Patent: 9
RemeGen Co., Ltd.
Shandong Sheng, China
Patent: 8
Bayer Intellectual Property GmbH
Nordrhein-Westfalen, Germany
Patent: 7
STARTUP
Navrogen, Inc.
Pennsylvania, United States
Patent: 6
F-Star Beta Ltd.
Cambridgeshire, United Kingdom
Patent: 6
F-star Therapeutics Ltd.
Cambridgeshire, United Kingdom
Patent: 5
Genentech, Inc.
California, United States
Patent: 4
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 8 patents, we discovered top 3 start-ups by total patent application.
STARTUP
Navrogen, Inc.
Pennsylvania, United States
Patent: 6
STARTUP
Arsenal Biosciences, Inc.
California, United States
Patent: 1
STARTUP
Anwita Biosciences, Inc.
California, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 86 patents applied in the last 5 years. We discover 22 most active companies in this area. The fast-growing Mogam Institute For Biomedical Research, Green Cross Corp., Silverback Therapeutics, Inc. take 54.65% of patent filing during this period.
Mogam Institute For Biomedical Research
Chungcheongnam-do, South Korea
Patent: 18
Green Cross Corp.
South Korea
Patent: 17
Silverback Therapeutics, Inc.
Washington, United States
Patent: 12
Development Center for Biotechnology
Taiwan Province, China
Patent: 8
RemeGen Co., Ltd.
Shandong Sheng, China
Patent: 8
F-Star Beta Ltd.
Cambridgeshire, United Kingdom
Patent: 6
STARTUP
Navrogen, Inc.
Pennsylvania, United States
Patent: 6
F-star Therapeutics Ltd.
Cambridgeshire, United Kingdom
Patent: 5
Novimmune SA
Genève, Switzerland
Patent: 4
GREEN CROSS CELL Corp.
South Korea
Patent: 3
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 86 patents in last 5 years, we discover 15 new entrants. Silverback Therapeutics, Inc., Development Center for Biotechnology, RemeGen Co., Ltd. are the most active new entrants in this area.
Silverback Therapeutics, Inc.
Washington, United States
Patent: 12
Development Center for Biotechnology
Taiwan Province, China
Patent: 8
RemeGen Co., Ltd.
Shandong Sheng, China
Patent: 8
F-Star Beta Ltd.
Cambridgeshire, United Kingdom
Patent: 6
STARTUP
Navrogen, Inc.
Pennsylvania, United States
Patent: 6
F-star Therapeutics Ltd.
Cambridgeshire, United Kingdom
Patent: 5
Novimmune SA
Genève, Switzerland
Patent: 4
GREEN CROSS CELL Corp.
South Korea
Patent: 3
UTC Therapeutics, Inc.
Shanghai Shi, China
Patent: 3
TeneoBio, Inc.
California, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 30 patents, we discovered top 2 universities and scientific research institutions by total patent application.
Okayama University
Okayama-ken, Japan
Patent: 4
Ludwig-Maximilians-Universität München
Bayern, Germany
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: